Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prepare More Data Earlier For Advisory Panels In Era Of Low Risk-Tolerance

This article was originally published in The Tan Sheet

Executive Summary

A stricter risk-tolerance environment at FDA means sponsors need to engage more in the advisory committee process and prepare to address real and perceived or hypothetical "data gaps.

You may also be interested in...



FDA Works To Ease “Traumatic” Advisory Committee Process – Ganley

Recognizing that planning and conducting advisory committee meetings can be "traumatic" for both government and industry, FDA is taking steps to improve the process, said Charles Ganley, the head of the agency's OTC drugs program

FDA Panel Narrowly Votes Against Cough/Cold Drugs For Children Up To Age 6

An FDA advisory panel decided in split votes Oct. 19 to recommend immediately that all OTC cough/cold medicines should not be used for 2-to 5-year-old children but are safe for 6- to 12-year-olds

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS101673

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel